Back to Search
LORI DAVIS, EDD
EDD
Speech-Language Pathologist
NPI: 1871680611Individual
Specialties, Licenses & Credentials
Speech-Language PathologistPrimary
Speech-Language Pathologist
Code: 235Z00000X
1006(OK)
Clinical Trials (5)
5
Linked Trials
0
Recruiting
1
With Results
An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder
NCT01587118COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial
NCT00203450COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD)
NCT00203463COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Carbamazepine Extended-Release for the Treatment of Bipolar Depression
NCT00203567COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder
NCT00203528COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (5)
An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder.
PMID 27738377·Psychopharmacol Bull·2016
8-other
Extended-release carbamazepine capsules : in bipolar I disorder.
PMID 16097852·CNS Drugs·2005
6-review
Pharmacological treatment of alcohol abuse/dependence with psychiatric comorbidity.
PMID 15112938·Alcohol Clin Exp Res·2004
7-preclinical
Topiramate in posttraumatic stress disorder: preliminary clinical observations.
PMID 11495099·J Clin Psychiatry·2001
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 600 S COLLEGE AVE
TULSA, OK 74104 - Phone
- (918) 631-2915
Quick Facts
- NPI
- 1871680611
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 5
- Publications
- 5
Are you this provider?
Claim Your Profile